Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.

Recall Number: D-0658-2020

Firm: Hikma Pharmaceuticals USA Inc.

Classification: Class II

Status: Terminated

Report Date: 20200122

Initiation Date: 20191217

Termination Date: 20210609

Reason for Recall

Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)

Product Description

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.